BACKGROUND AND AIMS: Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production. METHODOLOGY/PRINCIPAL FINDINGS: Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-γ) by histology, scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine interferon (IFN)-γ significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-γ induced the highest mucin secretion and greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-γ and enterobacteria. B. bifidum IATA-ES2 also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut mucosal protection. CONCLUSIONS: Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of CD pathogenesis.

Department of Immunology Institute of Microbiology v v i Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009;137:1912–1933. PubMed

Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169:345–350. PubMed PMC

Meresse B, Verdier J, Cerf-Bensussan N. The cytokine interleukin 21: a new player in coeliac disease? Gut. 2008;57:879–881. PubMed

Fina D, Sarra M, Caruso R, Del Vecchio Blanco G, Pallone F, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut. 2008;57:887–892. PubMed

van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007;39:827–829. PubMed PMC

Forsberg G, Fahlgren A, Hörstedt P, Hammarström S, Hernell O, et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol. 2004;99:894–904. PubMed

Nadal I, Donat E, Ribes-Koninckx, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56:1669–1674. PubMed

Collado MC, Calabuig M, Sanz Y. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol. 2007;8:9–14. PubMed

Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 2008;8:232–241. PubMed PMC

Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62:264–269. PubMed

Shan L, Marti T, Sollid LM, Gray GM, Khosla C. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J. 2004;383:311–318. PubMed PMC

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, et al. Identification of tissue transglutmainase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801. PubMed

Dubois PC, van Heel DA. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol. 2008;153:162–173. PubMed PMC

Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology. 2003;125:1105–1113. PubMed

Stepniak D, Koning F. Celiac disease–sandwiched between innate and adaptive immunity. Hum Immunol. 2006;67:460–468. PubMed

Palova-Jelinkova L, Rozkova D, Pecharova B, Bartova J, Sediva A, et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol. 2005;175:7038–7045. PubMed

Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 1994;106:533–539. PubMed

Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R, Stepankova R, Cukrowska B, et al. Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol. 2002;128:77–89. PubMed

Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun. 2009;1:123–135. PubMed PMC

Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Nethel-Arnett S, et al. Identificataion of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;39:16799–19804. PubMed PMC

Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins FEBS lett. 2005;579:4851–4855. PubMed

Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal lines. Scand J Gastroenterol. 2006;41:408–419. PubMed

Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity. Ann NY Acad Sci. 2009;1165:195–205. PubMed PMC

Sepp E, Julge K, Vasar M, Naaber P, Björksten B, et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr. 1997;86:956–961. PubMed

Kopecny J, Mrazek J, Fliegerova K, Frühauf P, Tuckova L. The intestinal microflora of childhood patients with indicated celiac disease. Folia Microbiol. 2008;53:214–216. PubMed

Sanchez E, Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, et al. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 2008;8:50–57. PubMed PMC

Tuckova L, Flegelova Z, Tlaskalova-Hogenova H, Zidek Z. Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J Leukoc Biol. 2000;67:312–318. PubMed

Cinova J, Palova-Jelinkova L, Smythies LE, Cerna M, Pecharova B, et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol. 2007;27:201–209. PubMed

Izquierdo E, Medina M, Ennahar S, Marchioni E, Sanz Y. Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains. Curr Microbiol. 2008;56:613–618. PubMed

Medina M, Izquierdo E, Ennahar S, Sanz Y. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol. 2007;150:531–538. PubMed PMC

Stepankova R. Rearing germfree rats and rabbits. Folia Microbiol. 1979;24:11–15. PubMed

Stepankova R, Tlaskalova-Hogenova H, Sinkora J, Jodl J, Fric P. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand J Gastroenterol. 1996;31:551–557. PubMed

Kverka M, Burianova J, Lodinova-Zadnikova R, Kocourkova I, Cinova J, et al. Cytokine profiling in human colostrum and milk by protein array. Clinical Chemistry. 2007;53:955–962. PubMed

Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–354. PubMed

Kandori H, Hirayama K, Takeda M, Doi K. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim. 1996;45:155–160. PubMed

Enss ML, Grosse-Siestrup H, Schmidt-Wittig U, Gartner K. Changes in colonic mucins of germfree rats in response to the introduction of a “normal” rat microbial flora. Rat colonic mucin. J Exp Anim Sci. 1992;35:110–119. PubMed

Sharma R, Schumacher U. Morphometric analysis of intestinal mucins under different dietary conditions and gut flora in rats. Dig Dis Sci. 1995;35:110–119. PubMed

Enss ML, Muller H, Schmidt-Wittig U, Kownatzki R, Coenen M, et al. Effects of perorally applied endotoxin on colonic mucins of germfree rats. Scand J Gastroenterol. 1996;31:868–874. PubMed

Deplancke B, Gaskins HR. Microbioal modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr. 2001;73:1131–1141. PubMed

Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interaction in an open mammalian ecosystem. Science. 1996;273:1380–1383. PubMed

Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;15:328–339. PubMed

Sharma R, Schumacher U, Ronaasen V, Coates M. Rat intestinal mucosal responses to a microbial flora and different diets. Gut. 1995;36:209–214. PubMed PMC

Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, et al. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut. 2000;46:218–224. PubMed PMC

Crabtree JE, Heatley RV, Losowsky MS. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. Gut. 1989;30:1339–1343. PubMed PMC

Barresi G, Tuccari G, Tedeschi A, Magazzu G. Lectin binding sites in duodeno-jejunal mucosae from coeliac children. Histochemistry. 1988;88:105–112. PubMed

Lindfors K, Blomqvist T, Juuti-Uusitalo K, Stenman S, Venäläinen J, et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 2008;152:552–558. PubMed PMC

Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology. 2005;129:1400–1413. PubMed

Beauchesne E, Desjardins P, Hazell AS, Butterworth RF. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain. Neurochem Int. 2009;55:275–281. PubMed

Ciccocioppo R, Finamore A, Ara C, Di Sabatino A, Mengheri E, et al. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol. 2006;125:502–511. PubMed

Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007;12:2:e1308. PubMed PMC

Daum S, Bauer U, Foss HD, Schuppan D, Stein H, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut. 1999;44:17–25. PubMed PMC

Salmela MT, MacDonald TT, Black D, Irvine B, Zhuma T, et al. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut. 2002;51:540–547. PubMed PMC

Zebrowska A, Narbutt J, Sysa-Jedrzejowska A, Kobos J, Waszczykowska E. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediators Inflamm. 2005;14:373–379. PubMed PMC

De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal advance: Bifidobacteria and gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J Leukoc Biol. 2010;87:765–778. PubMed

Finlay BB, Falkow S. Common themes in microbial pathogenicity revised. Microbiol Mol Biol Rev. 1997;61:136–169. PubMed PMC

Wilson M, McNab R, Henderson B. Vol. 656. Cambridge Univ Press; 2002. Bacterial Disease Mechanisms. 1st edn.

Diet Matters: Endotoxin in the Diet Impacts the Level of Allergic Sensitization in Germ-Free Mice

Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization

Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner